Michael Oelgeschläger

3.7k total citations
47 papers, 2.8k citations indexed

About

Michael Oelgeschläger is a scholar working on Molecular Biology, Small Animals and Physiology. According to data from OpenAlex, Michael Oelgeschläger has authored 47 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 6 papers in Small Animals and 5 papers in Physiology. Recurrent topics in Michael Oelgeschläger's work include Developmental Biology and Gene Regulation (11 papers), Pluripotent Stem Cells Research (10 papers) and TGF-β signaling in diseases (7 papers). Michael Oelgeschläger is often cited by papers focused on Developmental Biology and Gene Regulation (11 papers), Pluripotent Stem Cells Research (10 papers) and TGF-β signaling in diseases (7 papers). Michael Oelgeschläger collaborates with scholars based in Germany, United States and Netherlands. Michael Oelgeschläger's co-authors include Edward M. De Robertis, Juan Larraı́n, Oliver Wessely, Bernhard Lüscher, Eric Agius, Caroline Kemp, Bruno Reversade, Ulrich Rüther, Alfred Nordheim and Birgit Weinhold and has published in prestigious journals such as Nature, Environmental Science & Technology and The EMBO Journal.

In The Last Decade

Michael Oelgeschläger

46 papers receiving 2.7k citations

Peers

Michael Oelgeschläger
Grant N. Wheeler United Kingdom
Tien Hsu United States
Periannan Senapathy United States
Claire M. Schreiner United States
Bernhard Schmierer United Kingdom
Douglas A. Holtzman United States
Michael Oelgeschläger
Citations per year, relative to Michael Oelgeschläger Michael Oelgeschläger (= 1×) peers Tilman Borggrefe

Countries citing papers authored by Michael Oelgeschläger

Since Specialization
Citations

This map shows the geographic impact of Michael Oelgeschläger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Oelgeschläger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Oelgeschläger more than expected).

Fields of papers citing papers by Michael Oelgeschläger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Oelgeschläger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Oelgeschläger. The network helps show where Michael Oelgeschläger may publish in the future.

Co-authorship network of co-authors of Michael Oelgeschläger

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Oelgeschläger. A scholar is included among the top collaborators of Michael Oelgeschläger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Oelgeschläger. Michael Oelgeschläger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schönfelder, Gilbert, et al.. (2025). SP1 and p23 play a crucial role in the circadian target gene induction of activated aryl hydrocarbon receptor in human breast cells. Cell Biology and Toxicology. 41(1). 130–130.
2.
Park, Sung Bum, Eun‐Mi Kim, Ki Young Kim, et al.. (2024). hiPSC-derived macrophages improve drug sensitivity and selectivity in a macrophage-incorporating organoid culture model. Biofabrication. 16(3). 35021–35021. 5 indexed citations
4.
Oelgeschläger, Michael, et al.. (2020). A quantitative medium-throughput assay to measure Caenorhabditis elegans development and reproduction. STAR Protocols. 1(3). 100224–100224. 3 indexed citations
5.
Marx‐Stoelting, Philip, et al.. (2019). Caenorhabditis elegans As a Promising Alternative Model for Environmental Chemical Mixture Effect Assessment—A Comparative Study. Environmental Science & Technology. 53(21). 12725–12733. 48 indexed citations
6.
Piersma, Aldert H., Robert Landsiedel, Rebecca A. Clewell, et al.. (2019). Workshop on the validation and regulatory acceptance of innovative 3R approaches in regulatory toxicology – Evolution versus revolution. Toxicology in Vitro. 59. 1–11. 29 indexed citations
7.
Piersma, Aldert H., Bertrand Desprez, R. Taalman, et al.. (2018). Workshop on acceleration of the validation and regulatory acceptance of alternative methods and implementation of testing strategies. Toxicology in Vitro. 50. 62–74. 33 indexed citations
8.
Dunst, Sebastian, Norman Ertych, Verena Fetz, et al.. (2017). The AOP Concept: How Novel Technologies Can Support Development of Adverse Outcome Pathways. 3(3). 271–277. 3 indexed citations
9.
Luch, Andreas, et al.. (2016). Transgenic Mouse Models Transferred into the Test Tube: New Perspectives for Developmental Toxicity Testing In Vitro ?. Trends in Pharmacological Sciences. 37(10). 822–830. 2 indexed citations
10.
Kashef, Jubin, Tanja Diana, Michael Oelgeschläger, & Irina Nazarenko. (2012). Expression of the tetraspanin family members Tspan3, Tspan4, Tspan5 and Tspan7 during Xenopus laevis embryonic development. Gene Expression Patterns. 13(1-2). 1–11. 12 indexed citations
11.
Tralau, Tewes, Christian Riebeling, Ralph Pirow, et al.. (2012). Wind of Change Challenges Toxicological Regulators. Environmental Health Perspectives. 120(11). 1489–1494. 25 indexed citations
12.
Seiler, A., Michael Oelgeschläger, Manfred Liebsch, et al.. (2011). Developmental toxicity testing in the 21st century: the sword of Damocles shattered by embryonic stem cell assays?. Archives of Toxicology. 85(11). 1361–1372. 13 indexed citations
13.
Herr, Patrick, et al.. (2008). Regulation of TGF-β signalling by N-acetylgalactosaminyltransferase-like 1. Development. 135(10). 1813–1822. 30 indexed citations
14.
Oelgeschläger, Michael, et al.. (2004). Identification of a second Xenopus twisted gastrulation gene.. The International Journal of Developmental Biology. 48(1). 57–61. 10 indexed citations
15.
Oelgeschläger, Michael, Hiroki Kuroda, Bruno Reversade, & Edward M. De Robertis. (2003). Chordin Is Required for the Spemann Organizer Transplantation Phenomenon in Xenopus Embryos. Developmental Cell. 4(2). 219–230. 116 indexed citations
16.
Abreu, José G., Catherine Coffinier, Juan Larraı́n, Michael Oelgeschläger, & Edward M. De Robertis. (2002). Chordin-like CR domains and the regulation of evolutionarily conserved extracellular signaling systems. Gene. 287(1-2). 39–47. 142 indexed citations
17.
Wessely, Oliver, Eric Agius, Michael Oelgeschläger, Edgar M. Pera, & Edward M. De Robertis. (2001). Neural Induction in the Absence of Mesoderm: β-Catenin-Dependent Expression of Secreted BMP Antagonists at the Blastula Stage in Xenopus. Developmental Biology. 234(1). 161–173. 99 indexed citations
18.
Oelgeschläger, Michael, Juan Larraı́n, Douglas Geissert, & Edward M. De Robertis. (2000). The evolutionarily conserved BMP-binding protein Twisted gastrulation promotes BMP signalling. Nature. 405(6788). 757–763. 232 indexed citations
19.
Oelgeschläger, Michael, Issarang Nuchprayoon, Bernhard Lüscher, & Alan D. Friedman. (1996). C/EBP, c-Myb, and PU.1 Cooperate To Regulate the Neutrophil Elastase Promoter. Molecular and Cellular Biology. 16(9). 4717–4725. 207 indexed citations
20.
Coque, Juan José R., K Maeda, Michael Oelgeschläger, et al.. (1994). Possible involvement of the lysine  -aminotransferase gene (lat) in the expression of the genes encoding ACV synthetase (pcbAB) and isopenicillin N synthase (pcbC) in Streptomyces clavuligerus. Microbiology. 140(12). 3367–3377. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026